S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
NYSE:STE

STERIS - STE Stock Forecast, Price & News

$206.10
+1.18 (+0.58%)
(As of 01/27/2023 08:56 PM ET)
Add
Compare
Today's Range
$203.54
$206.36
50-Day Range
$177.21
$206.85
52-Week Range
$159.21
$255.93
Volume
276,900 shs
Average Volume
418,817 shs
Market Capitalization
$20.57 billion
P/E Ratio
N/A
Dividend Yield
0.92%
Price Target
$242.40

STERIS MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
17.6% Upside
$242.40 Price Target
Short Interest
Bearish
2.13% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-2.00
Upright™ Environmental Score
News Sentiment
0.39mentions of STERIS in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.78%
From $8.44 to $9.35 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.21 out of 5 stars

Medical Sector

418th out of 1,049 stocks

Surgical Appliances & Supplies Industry

10th out of 23 stocks


STE stock logo

About STERIS (NYSE:STE) Stock

STERIS Plc engages in the provision of healthcare and life science product and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment provides a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Mentor, OH.

Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

STE Stock News Headlines

Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
STERIS Second Quarter 2023 Earnings: Misses Expectations
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
STERIS Declares $0.47 per share Dividend
See More Headlines
Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

STE Company Calendar

Last Earnings
11/09/2022
Ex-Dividend for 12/16 Dividend
11/21/2022
Dividend Payable
12/16/2022
Today
1/30/2023
Next Earnings (Confirmed)
2/08/2023
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
85915210
Employees
16,422
Year Founded
1987

Price Target and Rating

Average Stock Price Forecast
$242.40
High Stock Price Forecast
$275.00
Low Stock Price Forecast
$210.00
Forecasted Upside/Downside
+17.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$243.89 million
Pretax Margin
1.17%

Debt

Sales & Book Value

Annual Sales
$4.78 billion
Cash Flow
$13.97 per share
Book Value
$65.36 per share

Miscellaneous

Free Float
98,875,000
Market Cap
$20.57 billion
Optionable
Optionable
Beta
0.80

Social Links


Key Executives

  • Daniel A. CarestioDaniel A. Carestio
    President, Chief Executive Officer & Director
  • Michael Joseph Tokich
    Chief Financial Officer & Senior Vice President
  • Kathleen Lynn Bardwell
    Chief Compliance Officer & Senior Vice President
  • John Adam ZangerleJohn Adam Zangerle
    Secretary, Senior Vice President & General Counsel
  • Renato G. Tamaro
    Treasurer & Vice President













STE Stock - Frequently Asked Questions

Should I buy or sell STERIS stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" STE shares.
View STE analyst ratings
or view top-rated stocks.

What is STERIS's stock price forecast for 2023?

5 Wall Street analysts have issued 12 month price objectives for STERIS's shares. Their STE share price forecasts range from $210.00 to $275.00. On average, they predict the company's stock price to reach $242.40 in the next twelve months. This suggests a possible upside of 17.6% from the stock's current price.
View analysts price targets for STE
or view top-rated stocks among Wall Street analysts.

How have STE shares performed in 2023?

STERIS's stock was trading at $184.69 at the beginning of the year. Since then, STE shares have increased by 11.6% and is now trading at $206.10.
View the best growth stocks for 2023 here
.

When is STERIS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 8th 2023.
View our STE earnings forecast
.

How can I listen to STERIS's earnings call?

STERIS will be holding an earnings conference call on Thursday, February 9th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "8550233".

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) released its quarterly earnings results on Wednesday, November, 9th. The medical equipment provider reported $1.99 earnings per share for the quarter, missing the consensus estimate of $2.00 by $0.01. The medical equipment provider had revenue of $1.20 billion for the quarter, compared to the consensus estimate of $1.22 billion. STERIS had a negative net margin of 0.17% and a positive trailing twelve-month return on equity of 12.75%. STERIS's revenue was up .3% on a year-over-year basis. During the same quarter last year, the firm earned $1.99 earnings per share.
Read the conference call transcript
.

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS announced a quarterly dividend on Wednesday, November 2nd. Stockholders of record on Tuesday, November 22nd will be given a dividend of $0.47 per share on Friday, December 16th. This represents a $1.88 annualized dividend and a yield of 0.91%. The ex-dividend date is Monday, November 21st.
Read our dividend analysis for STE
.

Is STERIS a good dividend stock?

STERIS (NYSE:STE) pays an annual dividend of $1.88 per share and currently has a dividend yield of 0.91%.
Read our dividend analysis for STE.

What guidance has STERIS issued on next quarter's earnings?

STERIS issued an update on its FY 2023 earnings guidance on Friday, December, 9th. The company provided earnings per share (EPS) guidance of $8.40-$8.60 for the period, compared to the consensus EPS estimate of $8.49. The company issued revenue guidance of $4.95 billion-$4.95 billion, compared to the consensus revenue estimate of $4.98 billion.

What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO?

196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees.

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are STERIS's major shareholders?

STERIS's stock is owned by a number of institutional and retail investors. Top institutional investors include Congress Asset Management Co. MA (0.59%), Villere ST Denis J & Co. LLC (0.33%), Boston Trust Walden Corp (0.24%), Boston Financial Mangement LLC (0.22%), Fenimore Asset Management Inc. (0.19%) and Copeland Capital Management LLC (0.18%). Insiders that own company stock include Cary L Majors, Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden and Walter M Rosebrough Jr.
View institutional ownership trends
.

How do I buy shares of STERIS?

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $206.10.

How much money does STERIS make?

STERIS (NYSE:STE) has a market capitalization of $20.57 billion and generates $4.59 billion in revenue each year. The medical equipment provider earns $243.89 million in net income (profit) each year or ($0.11) on an earnings per share basis.

How many employees does STERIS have?

The company employs 16,422 workers across the globe.

How can I contact STERIS?

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The official website for the company is www.steris.com. The medical equipment provider can be reached via phone at (440) 354-2600, via email at julie_winter@steris.com, or via fax at 440-639-4457.

This page (NYSE:STE) was last updated on 1/30/2023 by MarketBeat.com Staff